The identification and intervention of Alzheimer's Disease (AD) in its early-stage allows for the timely implementation of lifestyle modifications and therapeutic strategies. Although dysregulation of ...

For years, Robert F. Kennedy Jr. has raised questions about vaccine safety. Now, as the Secretary of Health and Human ...

A review paper published last year in European Journal of Medicinal Chemistry characterized Myc as the “oncogene from ...

Follow-up studies confirmed that this nucleoside modification improved mRNA translation capabilities and stability. In the last decade, a series of studies highlighted the powerful potential of ...

One study outlined the key areas that need to be overcome: the stability, immunogenicity, translation efficiency, and delivery of mRNA therapies. On the last point, there are already attempts to ...

Researchers from Eli Lilly & Co. reported preclinical data on LY-3954068, a MAPT small-interference RNA (siRNA) strategy in AD models. The therapy is designed to reduce tau protein synthesis by ...

CAMBRIDGE, MA / ACCESS Newswire / April 10, 2025 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 1, 2025 to ...

regulates the window of Bach2 expression, a transcription factor necessary for the transient expansion of B cells preceding plasma cell differentiation, via coupling its translation to its decay.

Each journal is staffed by professional editors who work in collaboration with one another and our international Editorial Advisory Boards of leading scientists. Please feel free to contact any of the ...